Testosterone
Resource Center
Featured
ACP 2025 Conference Coverage
ACP 2025 Conference Coverage
04/09/2025
Kate Young
Recent updates in endocrinology reveal fezolinetant as a promising non-hormonal treatment for menopausal symptoms and tirzepatide’s impressive 93% risk reduction in progression from prediabetes to type 2...
04/09/2025
02/19/2025
Kate Young
Darolutamide monotherapy reduced prostate-specific antigen response in patients with hormone-sensitive prostate cancer while maintaining testosterone levels in a recent 24-week randomized study.
02/19/2025
08/13/2022
How well do you know the Endocrine Society's guideline for testosterone therapy in men with hypogonadism? Test your knowledge in our latest quiz.
08/13/2022
Interactive Features
08/13/2022
How well do you know the Endocrine Society's guideline for testosterone therapy in men with hypogonadism? Test your knowledge in our latest quiz.
08/13/2022
